June 19th 2023
By Kristi Rosa
Patients with a subtype of lymphoma may be able to exclude radiotherapy if they respond to chemoimmunotherapy, although more follow-up is needed to assess potential long-term toxicities.
June 19th 2023
By Brielle Benyon
Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.
June 19th 2023
By Natasha Carlson
I learned that finding the right kind of support during and after a cancer diagnosis is truly invaluable.
June 19th 2023
By Debu Tripathy, M.D.
Researchers are looking for other ways to disrupt tumor cells in a way that better engages the immune system by exposing it to tumor antigens.
June 19th 2023
By Darlene Dobkowski, MA
Watch Dr. John O. Mascarenhas, from Icahn School of Medicine, discuss novel therapies in myelofibrosis during the CURE® Educated Patient® MPN Summit.
June 19, 2023 5:00 PM
By Natasha Carlson
June 17, 2023 6:00 PM
By Doris Helene White
June 16, 2023 5:00 PM
By Khevin Barnes
June 15, 2023 5:00 PM
By Steve Rubin
June 14, 2023 9:00 PM
June 9, 2023 1:00 PM
By Paul Gilbert
June 8, 2023 1:00 PM
By Catherine North
May 12, 2023 7:00 PM
By Bryana Tanner